Armata Pharmaceuticals, Inc.
ARMP
|
$2.5
-21.88%
0.0%
34K
|
Health Technology
(0.0% 1d) (-15.3% 1m) (97.7% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-83.49% volume)
Earnings Calendar:
Market Cap: $ 90,371,348
http://www.armatapharma.com
Sec Filling | Patents | 38 employees
(US) Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.
antibiotics msa antibiotic resistance injection
add to watch list Paper trade email alert is off
Press-releases
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
Published: 2024-03-21 (Crawled : 20:00) - prnewswire.com
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: 0.81%
H: 1.61%
C: 0.54%
update pharmaceuticals results
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
Published: 2024-03-04 (Crawled : 21:00) - prnewswire.com
INVA | $14.48 0.07% 0.07% 520K
|
Health Technology
|
| O: -0.33%
H: 0.3%
C: -2.17%
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: -2.91%
H: 0.0%
C: -5.75%
million pharmaceuticals agreement
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit
Published: 2024-02-21 (Crawled : 12:00) - prnewswire.com
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: -0.35%
H: 6.71%
C: 3.18%
presentation pharmaceuticals therapy
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: -2.85%
H: 12.55%
C: 12.13%
update pharmaceuticals results
Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: 2.18%
H: 12.11%
C: 7.84%
conference presentation fibrosis pharmaceuticals topline study
Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023
Published: 2023-10-19 (Crawled : 13:30) - biospace.com/
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: 6.7%
H: 0.45%
C: -4.84%
presentation pharmaceuticals global
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
Published: 2023-09-26 (Crawled : 14:00) - biospace.com/
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: 1.51%
H: 1.32%
C: -0.74%
sa02 pharmaceuticals study
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
Published: 2023-09-21 (Crawled : 13:30) - biospace.com/
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: -0.02%
H: 1.47%
C: -2.93%
conference pharmaceuticals global
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update
Published: 2023-08-14 (Crawled : 11:00) - prnewswire.com
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: 2.76%
H: 17.6%
C: -6.94%
update pharmaceuticals results
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics
Published: 2023-07-11 (Crawled : 14:00) - biospace.com/
INVA | $14.48 0.07% 0.07% 520K
|
Health Technology
|
| O: 0.0%
H: 1.05%
C: 1.05%
ARMP | $2.5 -21.88% 0.0% 34K
|
Health Technology
|
| O: 3.91%
H: 1.26%
C: -2.51%
pharmaceuticals therapeutics
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10